default author photo

Zhiyong Xu

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

60

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Therapeutic Targeting of Nsclc with Cudc-907: Dual Hdac/Pi3k Inhibition Mediates Growth Arrest and Cisplatin Resistance Reversion

Number of pages: 73 Posted: 23 Aug 2025
Li Yang, jiaji Wu, Mo Shen, Shumin Xu, Xinyuan Jiang, Mingshu Xiao, Zhiyong Xu, Yueli Shi, Jiangnan Zhao, Nana Liu, Yunke Yang, Jin Cheng, Junhui Sun, Xiaohong Guo, Pan Liu, Jiaqi Xu, Pingli Wang and Yun Xu
affiliation not provided to SSRN, affiliation not provided to SSRN, Zhejiang Chinese Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Zhejiang University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Zhejiang Cancer Hospital, Zhejiang University - Department of Pathology, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 60 (961,006)

Abstract:

Loading...

NSCLC, CUDC-907, HDAC, PI3K, cisplatin resistance, DNA damage